Practical Privacy Series 2013

Program

 

Chicago, IL
November 14: Healthcare Innovation Privacy

 

At-A-Glance

8:30 – 9:30 a.m.
Registration and Breakfast
9:30 – 9:45 a.m.
Welcome
9:45 – 11 a.m.
Specific Data Analytics and Utility within the Health Industry
11 – 11:15 a.m.
Refreshment Break
11:15 a.m. – 12:15 p.m. Biobanks, Pharmacogenomics Data and Personalized Medicine
12:15 – 1:15 p.m.
Lunch
1:15 – 2:30 p.m. Patient Engagement: Patient Access to Device, Sensor, Diagnostics and Other Real-time Data
2:30 – 3:30 p.m. Vendor and Data Strategy: The CVS Caremark Case Study
3:30 – 3:45 p.m. Refreshment Break
3:45 – 5 p.m. Closing Keynote
5 – 5:30 p.m. Wrap up and Next Steps

 

 

Specific Data Analytics and Utility within the Health Industry

Moderator: Stanley Crosley, CIPP/US, CIPM, Director, IU CLEAR Health Information, Crosley Law Offices, LLC
Sheila Colaclasure, CIPP/US, Americas Privacy and Public Policy Director, Acxiom Corporation
Kay Connelly
, Human Factors and Predictive Health Outcomes, Indiana University
Peter M. Lefkowitz, CIPP/US
, Chief Privacy Officer, General Electric Company

Join us to explore some of the leading questions in this area, including the following: What analytics are common in other or parallel industries? What data is useful and predictive? What is possible based on these practices for healthcare, and what are the issues to be aware of? What is the appropriate role for privacy?

Presentation 1, Presentation 2

Biobanks, Pharmacogenomics Data and Personalized Medicine

Moderator: Hilary M. Wandall, CIPP/US, CIPP/E, AVP, Compliance and Chief Privacy Officer, Merck & Co., Inc. 
Charlie Blanchard, CIPP/US, CIPP/E
, Director, Global Privacy Office, Amgen
Eric Meslin
, Executive Director, Center for Bioethics, IU Medical School

Come explore research, treatment and marketing in the new genetics-driven paradigm.

Presentation

Patient Engagement: Patient Access to Device, Sensor, Diagnostics and Other Real-time Data 

Moderator: Fred Cate, Distinguished Professor, Indiana University
Kay Connelly, Human Factors and Predictive Health Outcomes, Indiana University
Stanley Crosley, CIPP/US, CIPM, Director, IU CLEAR Health Information, Crosley Law Offices, LLC 
Kristen Knight, CIPP/US
, Senior Privacy Officer, Philips Electronics North America

We’ll use the project at CLEAR to prompt our discussion of the key considerations for patient direct access to data, as well as the possible uses and models that could evolve. We’ll also explore other data sources such as apps, sensors, diagnostics, as well as what data are most useful and the impact of these models on privacy and security.

Presentation

Vendor and Data Strategy: The CVS Caremark Case Study

Moderator: Stanley Crosley, CIPP/US, CIPM, Director, IU CLEAR Health Information, Crosley Law Offices, LLC
Jeff S. Donnell, President, NoMoreClipboard.com
Rick Kam, CIPP/US, President & Co-Founder, ID Experts
Jana Klopp, CIPP/US
, Director – Privacy, Eli Lilly and Co.
Ken Mortensen, CIPP/US, CIPP/G, CIPM, Vice President, Assistant General Counsel & Chief Privacy Officer, CVS Caremark Corporation

As more data moves outside of the enterprise and is managed and processed by third party vendors, it is essential that companies, especially in healthcare, understand and address risks related to vendor management. Join our panel of experts as they outline and describe the key elements of an effective vendor strategy and management program, including the reasons to have a vendor management program; vendor selection; vendor contracts; auditing and monitoring; pre- and post-contract risk and due-diligence assessments; privacy, data protection, security and compliance requirements; regulatory requirements; “selling” a vendor management program to your company; what to do when something goes wrong; working with colleagues in your company, including procurement, information security, legal and business managers; and a whole lot more. In this interactive session, you’ll gain practical tips for implementing and maintaining a comprehensive vendor management program, have the opportunity to have your questions answered during Q&As throughout the session.

Presentation 1, Presentation 2

Supplemental Materials